---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-012813"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:10:56.758644+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics settles governance lawsuit; annual director elections June 24, 2026

## Summary
- Stipulated consent judgment filed Feb 24 invalidates three-year director terms and for-cause removal from charter.
- Class action by Vladimir Gusinsky Revocable Trust will be dismissed with prejudice; charter corrected if court approves.
- Annual meeting set for June 24, 2026; record date April 27, 2026; agenda includes election of directors to one-year terms.
- Stockholder proposals and director nominations due by March 14, 2026; universal proxy notices due by April 13, 2026.

## SEC filing metadata
- accession: 0001628280-26-012813
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000162828026012813/0001628280-26-012813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000162828026012813/cntx-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-012813
- JSON: https://secwatch.observer/filing/0001628280-26-012813.json
- Plain text: https://secwatch.observer/filing/0001628280-26-012813.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.